Skip to main content

Table 1 Baseline characteristics according to coagulation status: Group I (low anticoagulation status) included patients with both INR below 2.0 and aPTT ratio below 1.50; Group II (adequate anticoagulation status) included patients with either INR ≥ 2.0 or aPTT ratio ≥ 1.50

From: Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation

  Overall Coagulation status at the time of event Coagulation status two weeks prior of event
  (n = 38) median (Q1-Q3) Group I (n = 12) Group II (n = 26) p Group I (n = 8) Group II (n = 30) p
Age 45 (36–54) 46 44 .94 45 45 .71
Male sex (%) 25 (66 %) 7 (58 %) 18 (69 %) .71 4 (50 %) 21 (70 %) .41
Smoking (%) 24 (63 %) 7 (58 %) 17 (65 %) .73 6 (75 %) 18 (60 %) .68
Diabetes (%) 2 (5 %) 1 (8 %) 1 (4 %) .54 0 2 (7 %) 1.0
Hypertension (%) 4 (11 %) 0 4 (15 %) .29 0 4 (13 %) .56
Hypercholesterolemia (%) 10 (26 %) 4 (33 %) 6 (23 %) .69 3 (38 %) 7 (23 %) .41
Prior MI (%) 5 (13 %) 1 (8 %) 4 (15 %) .99 2 (25 %) 3 (10 %) .28
Prior stroke (%) 4 (11 %) 2 (17 %) 2 (8 %) .58 0 4 (13 %) .56
Ischemic heart disease (%) 12 (32 %) 3 (25 %) 9 (35 %) .71 5 (63 %) 7 (23 %) .08
Hemoglobin 7.2 (6.5–7.9) 7.0 7.5 .23 6.4 7.4 .10
Leukocyte count 10.8 (8.3–13.9) 10.2 10.8 .75 8.5 10.8 .18
Platelet count 219 (164–296) 168 226 .34 192 226 .77
Creatinin 117 (96–150) 103 120 .11 119 114 .54
Blood urea nitrogen 10.6 (7.4–15.3) 90 11.8 .15 9.2 11.8 .31
ASAT 66 (32–192) 42 77 .24 126 62 .99
ALAT 71 (38–216) 53 77 .31 64 71 .57
LDH 481 (297–726) 354 542 .04 465 504 .68
Cardiac index 1.78 (1.50–2.01) 1.81 1.70 .77 1.86 1.69 .45
IABP treatment (%) 4 (11 %) 2 (17 %) 2 (8 %) .58 1 (13 %) 3 (10 %) .99
Temporary VAD (%) 4 (11 %) 2 (17 %) 2 (8 %) .58 2 (25 %) 2 (7 %) .19
Concomitant RVAD 0 0 0 - 0 0 -